Diociaiuti Andrea, El Hachem May, Pisaneschi Elisa, Giancristoforo Simona, Genovese Silvia, Sirleto Pietro, Boldrini Renata, Angioni Adriano
Dermatology Unit, Bambino Gesù Children's Hospital, IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.
Molecular Genetics Laboratory, Medical Genetics Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Orphanet J Rare Dis. 2016 Jan 13;11:4. doi: 10.1186/s13023-016-0384-4.
The term ichthyosis describes a generalized disorder of cornification characterized by scaling and/or hyperkeratosis of different skin regions. Mutations in a broad group of genes related to keratinocyte differentiation and epidermal barrier function have been demonstrated to play a causative role in disease development. Ichthyosis may be classified in syndromic or non-syndromic forms based on the occurrence or absence of extracutaneous signs. In this setting, the diagnosis of ichthyosis is an integrated multistep process requiring a multidisciplinary approach in order to formulate the appropriate diagnostic hypothesis and to address the genetic testing.
Due to the complex features of the different ichthyoses and the high number of genes involved we have investigated a group of 64 patients, affected by syndromic and non-syndromic diseases, using Next Generation Sequencing as a new tool for the molecular diagnosis.
Using this innovative molecular approach we were able to find pathogenic mutations in 53 out of 64 patients resulting in 82.8 % total detection rate. An interesting result from the analysis of the data is the high rate of novel sequence variations found compared to known mutations and the relevant rate of homozygous mutations.
The possibility to analyze a large number of genes associated with various diseases allows to study cases with phenotypes not well-determined, giving the opportunity to make new genotype-phenotype correlation. In some cases there were discrepancies between clinical features and histology or electron microscopy and only molecular analysis allowed to definitively resolve the diagnostic dilemma. The genetic diagnosis of ichthyosis leads to a more accurate and effective genetic counseling, allowing correct evaluation of the risk of recurrence, particularly in families with consanguineous background.
鱼鳞病是一种以不同皮肤区域出现鳞屑和/或角化过度为特征的全身性角化异常疾病。已证实与角质形成细胞分化和表皮屏障功能相关的一大类基因突变在疾病发展中起致病作用。根据是否存在皮肤外体征,鱼鳞病可分为综合征型或非综合征型。在这种情况下,鱼鳞病的诊断是一个综合的多步骤过程,需要多学科方法来制定适当的诊断假设并进行基因检测。
由于不同鱼鳞病的复杂特征以及涉及的基因数量众多,我们使用下一代测序作为分子诊断的新工具,对一组64例受综合征型和非综合征型疾病影响的患者进行了研究。
使用这种创新的分子方法,我们在64例患者中的53例中发现了致病突变,总检测率为82.8%。数据分析的一个有趣结果是,与已知突变相比,新发现的序列变异率很高,纯合突变率也很高。
分析大量与各种疾病相关基因的可能性使得能够研究表型不确定的病例,从而有机会建立新的基因型-表型相关性。在某些情况下,临床特征与组织学或电子显微镜检查结果之间存在差异,只有分子分析才能最终解决诊断难题。鱼鳞病的基因诊断有助于进行更准确有效的遗传咨询,从而正确评估复发风险,尤其是在有近亲背景的家庭中。